AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. TBPH
  4. [Form 4] Theravance Biopharma, Inc. Insider Trading Activity

[Form 4] Theravance Biopharma, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source:

Stock TBPH logo
Theravance Bioph

NASDAQ:TBPH

TBPH Rankings

#2976 Ranked by Market Cap
N/A Ranked by Dividends

TBPH Latest News

Aug 25, 2025
Theravance Biopharma Completes Enrollment in Pivotal Phase 3 CYPRESS Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension due to Multiple System Atrophy
Aug 12, 2025
Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Jul 28, 2025
Theravance Biopharma to Report Second Quarter 2025 Financial Results on August 12, 2025
Jul 23, 2025
Theravance Biopharma to Participate in an Upcoming Investor Conference
Jun 26, 2025
Theravance Biopharma Announces Approval of YUPELRI庐 (revefenacin) by China's NMPA

TBPH Latest SEC Filings

Aug 25, 2025
[8-K] Theravance Biopharma, Inc. Reports Material Event
Aug 22, 2025
[Form 4] Theravance Biopharma, Inc. Insider Trading Activity
Aug 22, 2025
[Form 4] Theravance Biopharma, Inc. Insider Trading Activity
Aug 22, 2025
[Form 4] Theravance Biopharma, Inc. Insider Trading Activity
Aug 22, 2025
[Form 4] Theravance Biopharma, Inc. Insider Trading Activity

TBPH Stock Data

700.53M
48.06M
4.45%
92.05%
8.25%
Biotechnology
Pharmaceutical Preparations
United States
GEORGE TOWN, GRAND CAYMAN